These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact. Devkota AK; Tavares CD; Warthaka M; Abramczyk O; Marshall KD; Kaoud TS; Gorgulu K; Ozpolat B; Dalby KN Biochemistry; 2012 Mar; 51(10):2100-12. PubMed ID: 22352903 [TBL] [Abstract][Full Text] [Related]
5. Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor. Piserchio A; Isiorho EA; Dalby KN; Ghose R J Biol Chem; 2023 Jun; 299(6):104813. PubMed ID: 37172726 [TBL] [Abstract][Full Text] [Related]
6. What is the impact of eukaryotic elongation factor 2 kinase on cancer: A systematic review. Li S; Li Y; Bai Y Eur J Pharmacol; 2019 Aug; 857():172470. PubMed ID: 31226250 [TBL] [Abstract][Full Text] [Related]
7. From Enzyme to Whole Blood: Sequential Screening Procedure for Identification and Evaluation of p38 MAPK Inhibitors. Bauer SM; Kubiak JM; Rothbauer U; Laufer S Methods Mol Biol; 2016; 1360():123-48. PubMed ID: 26501907 [TBL] [Abstract][Full Text] [Related]
8. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II). Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223 [TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of tagless recombinant human elongation factor 2 kinase (eEF-2K) expressed in Escherichia coli. Abramczyk O; Tavares CD; Devkota AK; Ryazanov AG; Turk BE; Riggs AF; Ozpolat B; Dalby KN Protein Expr Purif; 2011 Oct; 79(2):237-44. PubMed ID: 21605678 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of pyrido[2,3-d]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors. Edupuganti R; Wang Q; Tavares CD; Chitjian CA; Bachman JL; Ren P; Anslyn EV; Dalby KN Bioorg Med Chem; 2014 Sep; 22(17):4910-6. PubMed ID: 25047940 [TBL] [Abstract][Full Text] [Related]
11. Reversible covalent inhibition of eEF-2K by carbonitriles. Devkota AK; Edupuganti R; Yan C; Shi Y; Jose J; Wang Q; Kaoud TS; Cho EJ; Ren P; Dalby KN Chembiochem; 2014 Nov; 15(16):2435-42. PubMed ID: 25224652 [TBL] [Abstract][Full Text] [Related]
12. Integration of virtual screening with high-throughput screening for the identification of novel Rho-kinase I inhibitors. Gong LL; Fang LH; Peng JH; Liu AL; Du GH J Biotechnol; 2010 Feb; 145(3):295-303. PubMed ID: 19963024 [TBL] [Abstract][Full Text] [Related]
13. Structure prediction of eukaryotic elongation factor-2 kinase and identification of the binding mechanisms of its inhibitors: homology modeling, molecular docking, and molecular dynamics simulation. Tatar G; Taskin Tok T; Ozpolat B; Ay M J Biomol Struct Dyn; 2022; 40(24):13355-13365. PubMed ID: 30880628 [TBL] [Abstract][Full Text] [Related]
14. From one well to 9000: using high-density streptavidin-coated membranes for kinase detection. Curtin M; Watson J; Goueli S Biotechniques; 2002 Oct; Suppl():107-11. PubMed ID: 12395935 [TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Molecular Modeling Studies of Novel Coumarin Carboxamide Derivatives as eEF-2K Inhibitors. Comert Onder F; Durdagi S; Sahin K; Ozpolat B; Ay M J Chem Inf Model; 2020 Mar; 60(3):1766-1778. PubMed ID: 32027127 [TBL] [Abstract][Full Text] [Related]
16. HTRF Kinase Assay Development and Methods in Inhibitor Characterization. Jia Y; Manuia M; Juarez J Methods Mol Biol; 2016; 1360():1-18. PubMed ID: 26501898 [TBL] [Abstract][Full Text] [Related]
17. Screening for Inhibitors of Kinase Autophosphorylation. Heedmann B; Klumpp M Methods Mol Biol; 2016; 1439():159-69. PubMed ID: 27316994 [TBL] [Abstract][Full Text] [Related]
18. Fluorescent biosensors for high throughput screening of protein kinase inhibitors. Prével C; Pellerano M; Van TN; Morris MC Biotechnol J; 2014 Feb; 9(2):253-65. PubMed ID: 24357625 [TBL] [Abstract][Full Text] [Related]
19. Protein kinases: From targets to anti-cancer drugs. Cruzalegui F Ann Pharm Fr; 2010 Jul; 68(4):254-9. PubMed ID: 20637357 [TBL] [Abstract][Full Text] [Related]
20. Development of a cell-based, high-throughput screening assay for ATM kinase inhibitors. Guo K; Shelat AA; Guy RK; Kastan MB J Biomol Screen; 2014 Apr; 19(4):538-46. PubMed ID: 24464432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]